NewsLife Sciences
TopoTarget Announces New Preclinical Results with Belinostat to be presented at AACR Annual Meeting
12 Apr 2007Product news
TopoTarget A/S announced today that new preclinical data on belinostat (PXD101), a histone deacetylase (HDAC) inhibitor being investigated for the treatment of cancer, will be presented at the upcoming American Association for Cancer Research (AACR) 2007 Annual Meeting in Los Angeles, April 14-18, 2007. A total of five poster presentations on belinostat (PXD101) will be made during the conference.
Belinostat (PXD101), HDAC inhibitor for the treatment of cancer:
- “Activity of PXD101, an HDAC inhibitor, used alone or in combination with 5-FU in preclinical gastroesophageal studies,” (Abstract #691) during the conference’s HDAC Inhibitors I poster session on Sunday, April 15th in the Exhibit Hall on Poster Board #14
- “Gene expression screen in cell panel selected for varying sensitivity towards the Histone Deacetylase inhibitor (HDACi) PXD101 reveals potential predictors of HDACi sensitivity,” (Abstract #687) during the conference’s HDAC Inhibitors I poster session on Sunday, April 15th in the Exhibit Hall on Poster Board #10
- “The effect of the histone deacetylase inhibitor (HDACi) PXD101 on cell growth and expression of viral and host genes in hepatitis B virus (HBV)-carrying hepatocellular carcinoma (HCC) cell lines,” (Abstract #696) during the conference’s HDAC Inhibitors I poster session on Sunday, April 15th in the Exhibit Hall on Poster Board #19
- “The histone deacetylase (HDAC) inhibitor PXD101 suppresses bladder cancer cell growth both in-vitro and in-vivo,” (Abstract #2211) during the conference’s Mouse Models of Cancer 2: Therapeutic Approaches poster session on Monday, April 16th on Poster Board #9
- “The HDAC inhibitors romidepsin and PXD101 interact synergistically with Bortezomib in human chronic lymphocytic leukemia (CLL) cells in association with NF-κB inactivation,” (Abstract #1835) during the conference’s Targeted Agents and Other Novel Therapies poster session on Monday, April 16th on Poster Board #21
Links
Tags
Cell / Tissue CultureCell culture or tissue culture is used to study the biology of cells or tissues and to isolate cellular products in an environment which can be manipulated and well defined. Accurately control your culture environment with bioreactors or culture incubators, bind your cells to a surface or together with an extracellular matrix. Distinguish cell types with differential media or proliferate cells with certain characteristics using selective media. Enrich your media with supplements such as growth factors, sera and vitamins. Find the best cell and tissue culture products, kits and equipment in our peer-reviewed product directory: compare products, check customer reviews and receive pricing direct from manufacturers.Cell Lines Stem Cells and Primary CellsPrimary cell cultures, established cell lines and stem cells are vital for <i>in vitro</i> and <i>ex vivo</i> experimentation. High-quality cells, optimized for your applications, alongside optimized cell substrates, growth medium and supplements, are critical for experimental success. Explore a range of cells suitable for your applications, including isogenic cell lines, competent cells, induced pluripotent stem cell (iPSC)-derived cell lines, fungal/bacterial/mammalian cell lines, stem cells and cancer cell lines. Find the best cells for your research in our peer-reviewed product directory: compare products, check customer reviews and receive pricing direct from manufacturers.Clinical TrialsClinical Trials, an essential part of drug discovery process, assess the safety and effectiveness of a new medication or device in the pharmaceutical industry. Clinical Trials are a phased process (Phase 0, Phase I, Phase II, Phase III and Phase IV) which begins after initial preclinical testing.